MANNKIND CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.79 USD | -0.62% |
|
+4.36% | +31.59% |
| 08/05 | Transcript : MannKind Corporation, Q1 2024 Earnings Call, May 08, 2024 | |
| 08/05 | Earnings Flash (MNKD) MANNKIND Posts Q1 EPS $0.05 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 130.17Cr | - | |||||
| 12TCr | ||||||
| 11TCr | ||||||
| 2.34TCr | - | |||||
| 2.18TCr | - | |||||
| 1.81TCr |
